Atg10 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Atg10 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| ATG10 Protein | |
|---|---|
| Protein Name | Autophagy Related 10 |
| Gene | ATG10 |
| UniProt ID | Q9Y4K0 |
| PDB Structure | 2DUT, 2LKK |
| Molecular Weight | 20 kDa |
| Subcellular Localization | Cytoplasm |
| Protein Family | E2-like Conjugating Enzyme |
ATG10 is a 182-amino acid E2-like conjugating enzyme. It contains the characteristic E2 enzyme core with catalytic cysteine residue required for ubiquitin-like (Ubl) conjugation. ATG10 lacks the N-terminal extension found in some E2 enzymes but maintains the conserved UBC fold.
ATG10 catalyzes the conjugation of ATG12 to ATG5, an essential step in autophagosome formation. This ubiquitin-like conjugation system requires the action of E1 (ATG7) and E2 (ATG10) enzymes. The ATG12-ATG5 conjugate then forms a complex with ATG16L1, which functions as an E3 ligase for LC3 lipidation. This pathway is essential for autophagosome biogenesis.
| Disease | Mechanism | Evidence |
|---|---|---|
| Parkinson's Disease | Impaired autophagy leads to alpha-synuclein accumulation. | Genetic studies |
| Alzheimer's Disease | Reduced autophagy contributes to amyloid accumulation. | Post-mortem studies |
| Cancer | Autophagy has context-dependent roles in tumor survival. | Clinical studies |
| Liver disease | Impaired hepatic autophagy causes metabolic dysfunction. | Animal models |
Atg10 Protein plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Atg10 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.